Title : Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBPalpha in human umbilical vein endothelial cells from gestational diabetes.

Pub. Date : 2010 Apr 1

PMID : 20032083






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBPalpha in human umbilical vein endothelial cells from gestational diabetes. Nitric Oxide solute carrier family 29 member 1 (Augustine blood group) Homo sapiens
2 AIMS: Reduced expression of human equilibrative nucleoside transporter 1 (hENT1) results from nitric oxide (NO)-dependent reduced SLC29A1 transcriptional activity in human umbilical vein endothelial cells (HUVECs) from gestational diabetes. Nitric Oxide solute carrier family 29 member 1 (Augustine blood group) Homo sapiens
3 AIMS: Reduced expression of human equilibrative nucleoside transporter 1 (hENT1) results from nitric oxide (NO)-dependent reduced SLC29A1 transcriptional activity in human umbilical vein endothelial cells (HUVECs) from gestational diabetes. Nitric Oxide solute carrier family 29 member 1 (Augustine blood group) Homo sapiens
4 AIMS: Reduced expression of human equilibrative nucleoside transporter 1 (hENT1) results from nitric oxide (NO)-dependent reduced SLC29A1 transcriptional activity in human umbilical vein endothelial cells (HUVECs) from gestational diabetes. Nitric Oxide solute carrier family 29 member 1 (Augustine blood group) Homo sapiens